Literature DB >> 21873432

Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling.

Samar Abdulkhalek1, Schammim Ray Amith, Susan L Franchuk, Preethi Jayanth, Merry Guo, Trisha Finlay, Alanna Gilmour, Christina Guzzo, Katrina Gee, Rudi Beyaert, Myron R Szewczuk.   

Abstract

The signaling pathways of mammalian Toll-like receptors (TLRs) are well characterized, but the precise mechanism(s) by which TLRs are activated upon ligand binding remains poorly defined. Recently, we reported a novel membrane sialidase-controlling mechanism that depends on ligand binding to its TLR to induce mammalian neuraminidase-1 (Neu1) activity, to influence receptor desialylation, and subsequently to induce TLR receptor activation and the production of nitric oxide and proinflammatory cytokines in dendritic and macrophage cells. The α-2,3-sialyl residue of TLR was identified as the specific target for hydrolysis by Neu1. Here, we report a membrane signaling paradigm initiated by endotoxin lipopolysaccharide (LPS) binding to TLR4 to potentiate G protein-coupled receptor (GPCR) signaling via membrane Gα(i) subunit proteins and matrix metalloproteinase-9 (MMP9) activation to induce Neu1. Central to this process is that a Neu1-MMP9 complex is bound to TLR4 on the cell surface of naive macrophage cells. Specific inhibition of MMP9 and GPCR Gα(i)-signaling proteins blocks LPS-induced Neu1 activity and NFκB activation. Silencing MMP9 mRNA using lentivirus MMP9 shRNA transduction or siRNA transfection of macrophage cells and MMP9 knock-out primary macrophage cells significantly reduced Neu1 activity and NFκB activation associated with LPS-treated cells. These findings uncover a molecular organizational signaling platform of a novel Neu1 and MMP9 cross-talk in alliance with TLR4 on the cell surface that is essential for ligand activation of TLRs and subsequent cellular signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873432      PMCID: PMC3196117          DOI: 10.1074/jbc.M111.237578

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Ligand-induced conformational changes allosterically activate Toll-like receptor 9.

Authors:  Eicke Latz; Anjali Verma; Alberto Visintin; Mei Gong; Cherilyn M Sirois; Dionne C G Klein; Brian G Monks; C James McKnight; Marc S Lamphier; W Paul Duprex; Terje Espevik; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2007-06-17       Impact factor: 25.606

Review 2.  Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.

Authors:  Jialiang Hu; Philippe E Van den Steen; Qing-Xiang A Sang; Ghislain Opdenakker
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

3.  The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.

Authors:  Tobias Haas; Jochen Metzger; Frank Schmitz; Antje Heit; Thomas Müller; Eicke Latz; Hermann Wagner
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

4.  An efficient culture method for generating large quantities of mature mouse splenic macrophages.

Authors:  Attiya Alatery; Sameh Basta
Journal:  J Immunol Methods       Date:  2008-08-26       Impact factor: 2.303

5.  Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity.

Authors:  Prasad Rallabhandi; Quan M Nhu; Vladimir Y Toshchakov; Wenji Piao; Andrei E Medvedev; Morley D Hollenberg; Alessio Fasano; Stefanie N Vogel
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

6.  Neuraminidase 1 is a negative regulator of lysosomal exocytosis.

Authors:  Gouri Yogalingam; Erik J Bonten; Diantha van de Vlekkert; Huimin Hu; Simon Moshiach; Samuel A Connell; Alessandra d'Azzo
Journal:  Dev Cell       Date:  2008-07       Impact factor: 12.270

Review 7.  Plasma membrane-associated sialidase as a crucial regulator of transmembrane signalling.

Authors:  Taeko Miyagi; Tadashi Wada; Kazunori Yamaguchi; Keiko Hata; Kazuhiro Shiozaki
Journal:  J Biochem       Date:  2008-07-16       Impact factor: 3.387

8.  TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells.

Authors:  Mehmet A Eskan; Beate G Rose; Manjunatha R Benakanakere; Qun Zeng; Daisuke Fujioka; Michael H Martin; Menq-Jer Lee; Denis F Kinane
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

9.  Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages.

Authors:  Katie Loniewski; Yuhui Shi; James Pestka; Narayanan Parameswaran
Journal:  Mol Immunol       Date:  2008-01-04       Impact factor: 4.407

10.  The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.

Authors:  Sarah E Ewald; Bettina L Lee; Laura Lau; Katherine E Wickliffe; Guo-Ping Shi; Harold A Chapman; Gregory M Barton
Journal:  Nature       Date:  2008-09-28       Impact factor: 49.962

View more
  40 in total

1.  Loss of CMAH during Human Evolution Primed the Monocyte-Macrophage Lineage toward a More Inflammatory and Phagocytic State.

Authors:  Jonathan J Okerblom; Flavio Schwarz; Josh Olson; William Fletes; Syed Raza Ali; Paul T Martin; Christopher K Glass; Victor Nizet; Ajit Varki
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

Review 2.  Lysosomal multienzyme complex: pros and cons of working together.

Authors:  Erik J Bonten; Ida Annunziata; Alessandra d'Azzo
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

3.  Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.

Authors:  Irina G Luzina; Erik P Lillehoj; Virginia Lockatell; Sang W Hyun; Katerina N Lugkey; Akihiro Imamura; Hideharu Ishida; Christopher W Cairo; Sergei P Atamas; Simeon E Goldblum
Journal:  J Pharmacol Exp Ther       Date:  2020-11-02       Impact factor: 4.030

4.  Neuraminidase activity mediates IL-6 production by activated lupus-prone mesangial cells.

Authors:  Kamala Sundararaj; Jessalyn I Rodgers; Subathra Marimuthu; Leah J Siskind; Evelyn Bruner; Tamara K Nowling
Journal:  Am J Physiol Renal Physiol       Date:  2017-12-20

5.  MMP-9-induced increase in intestinal epithelial tight permeability is mediated by p38 kinase signaling pathway activation of MLCK gene.

Authors:  Rana Al-Sadi; Moustafa Youssef; Manmeet Rawat; Shuhong Guo; Karol Dokladny; Mohammad Haque; Martin D Watterson; Thomas Y Ma
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-12-13       Impact factor: 4.052

6.  Sialidases as regulators of bioengineered cellular surfaces.

Authors:  Cristina Y Zamora; Matthew J Ryan; Marc d'Alarcao; Krishna Kumar
Journal:  Glycobiology       Date:  2015-03-20       Impact factor: 4.313

Review 7.  Molecular mechanisms of regulation of Toll-like receptor signaling.

Authors:  Cynthia A Leifer; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2016-06-24       Impact factor: 4.962

8.  Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis.

Authors:  Irina G Luzina; Virginia Lockatell; Sang W Hyun; Pavel Kopach; Phillip H Kang; Zahid Noor; Anguo Liu; Erik P Lillehoj; Chunsik Lee; Alba Miranda-Ribera; Nevins W Todd; Simeon E Goldblum; Sergei P Atamas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-03-18       Impact factor: 5.464

9.  Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice.

Authors:  Abraham Yang; Gabriel Gyulay; Mark Mitchell; Elizabeth White; Bernardo L Trigatti; Suleiman A Igdoura
Journal:  J Lipid Res       Date:  2012-09-14       Impact factor: 5.922

10.  The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.

Authors:  Sang W Hyun; Anguo Liu; Zhenguo Liu; Alan S Cross; Avelino C Verceles; Sadagopan Magesh; Yadagiri Kommagalla; Chandrababunaidu Kona; Hiromune Ando; Irina G Luzina; Sergei P Atamas; Kurt H Piepenbrink; Eric J Sundberg; Wei Guang; Hideharu Ishida; Erik P Lillehoj; Simeon E Goldblum
Journal:  Glycobiology       Date:  2016-05-25       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.